Free gingival graft with apical flap repositioningFree gingival graft with vestibular mucosa excision
Free gingival graft with apical flap repositioning: Autologous free gingival graft harvested from the palate and placed at the recipient site. The vestibular mucosal flap is repositioned apically and sutured to the periosteum during second-stage implant surgery.
Free gingival graft with vestibular mucosa excision: Autologous free gingival graft harvested from the palate and placed at the recipient site. The vestibular mucous tissue is excised during second-stage implant surgery.
Study summary
The goal of this clinical trial is to learn which surgical technique works better to increase the amount of firm gum tissue (called keratinized mucosa) around dental implants in adults.
The main question it aims to answer is:
-Does repositioning the gum flap upward with stitches lead to a greater gain in firm gum tissue width at 6 months compared to simply removing the extra gum tissue, when both techniques are combined with a free gum graft?
Researchers will compare two techniques used during the second stage of implant surgery to see which one produces a greater gain in firm gum tissue around the implant.
Participants will:
* Receive a free gum graft (a small piece of tissue taken from the roof of the mouth) placed around their dental implant during a routine surgical visit
* Be randomly assigned to one of the two surgical techniques
* Have digital scans of their mouth taken at 5 timepoints over 6 months
* Complete a pain diary and answer questions about their experience during the first week after surgery
* Attend follow-up visits at 6 weeks, 3 months, and 6 months after surgery
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Men or women aged 18 years or older who voluntarily agree to sign the informed consent form before any study-related procedure is performed.
* Single or multiple edentulous spaces (≤3 units) located in the posterior maxilla or mandible, presenting osseointegrated implants in first-stage surgery with a -healing period of more than 8 weeks.
* ASA classification I or II.
* Periodontal and peri-implant health.
* O'Leary plaque index ≤15%.
* Keratinized mucosa width ≤2 mm and/or vestibular depth \<4 mm at at least one site.
* Commitment to attend all follow-up visits over 6 months.
Exclusion Criteria:
* Systemic diseases that may interfere with performing FGG (free gingival graft), including but not limited to: poorly controlled diabetes mellitus (HbA1c \> 8% or per clinical judgment), immunodeficiencies or immunosuppressive treatment, uncontrolled hematological diseases or coagulation disorders, anticoagulant or antiplatelet treatment that cannot be adjusted according to standard clinical practice, active neoplasms under treatment, severe renal or hepatic insufficiency, decompensated cardiovascular diseases, and any other medical condition that, in the investigator's judgment, could compromise participant safety or proper tissue healing.
* Any contraindication to oral surgical procedures.
* Periodontal and peri-implant health as defined by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
* Patients who smoke tobacco or equivalent products, as well as former smokers with an abstinence period ≤12 months.
* History of substance abuse (drugs or alcohol) or any other factor (e.g., severe psychiatric illness) that, in the investigator's opinion, could interfere with the patient's ability to cooperate and comply with the study.
* Patients who have participated in a clinical trial within the last 30 days.
* Pregnant or breastfeeding women.
Primary outcome measure(s)
Peri-implant keratinized tissue width (KTW) gain — Baseline (T0) to 6 months (T6m) Absolute change in KTW, measured digitally as the linear distance between the mucosal margin and the mucogingival junction on the vestibular aspect of the implant, using Geomagic Control X® software on intraoral scan models (TRIOS 3®, 3Shape).
Trial sites (1)
Facility
City
Region
Status
Hospital Odontològic Universitat de Barcelona, L'Hospitalet de Llobregat,
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.